English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 851778 Online Users : 1068
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
張俊彥
--報告
--專利
--期刊論文
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
張俊彥
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
報告
[
0
/1]
專利
[
0
/11]
期刊論文
[
193
/194]
會議論文/會議摘要
[
41
/48]
Siblings
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
66
/71]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
Community Statistics
近3年內發表的文件:0(0.00%)
含全文筆數:234(92.13%)
文件下載次數統計
下載大於0次:234(100.00%)
下載大於100次:234(100.00%)
檔案下載總次數:146303(2.73%)
最後更新時間: 2024-11-28 10:27
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Identification of prognostic biomar...
A novel NRF2/ARE inhibitor gossypol...
Targeting lysosomal cysteine protea...
c-MYC-directed NRF2 drives malignan...
Ephrin A4-ephrin receptor A10 signa...
Phase I dose-escalation study of SC...
Germline susceptibility variants im...
Index of cancer-associated fibrobla...
The SMAC mimetic LCL161 is a direct...
The tumor suppressor TGFBR3 blocks ...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-25 of 254. (11 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2021-12-14
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-16
Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues
Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
2021-04
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors
Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-11
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy
Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-01-12
Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells
Scientific Reports. 2021 Jan 12;11:Article number 644.
2020-08
The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells
Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
2020-07-17
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.]
Scientific Reports. 2020 Jul 17;10:Article number 12216.
2020-06-28
Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction
Cancers. 2020 Jun 28;12(7):Article number 1718.
2020-06
Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice
European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
2020-05-27
The tumor suppressor TGFBR3 blocks lymph node metastasis in head and neck cancer
Cancers. 2020 May 27;12(6):Article number 1375.
2020-04-02
MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
Journal of Biomedical Science. 2020 Apr 2;27:Article number 46.
2020-03-31
Discoidin domain receptor-1 (DDR1) is involved in angiolymphatic invasion in oral cancer
Cancers. 2020 Mar 31;12(4):Article number 841.
2019-12
Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry
Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
2019-08-24
New insights into mechanisms of cisplatin resistance: From tumor cell to microenvironment
International Journal of Molecular Sciences. 2019 Aug 24;20(17):Article number 4136.
2019-07
Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942.
2019-06-01
Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells
International Journal of Cancer. 2019 Jun 1;144(11):2795-2810.
2019-06
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
Head and Neck. 2019 Jun;41(6):1703-1712.
2019-06
Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer
Alcoholism, Clinical and Experimental Research. 2019 Jun;43(6):1225-1233.
2019-04
Oral hygiene and the overall survival of head and neck cancer patients
Cancer Medicine. 2019 Apr;8(4):1854-1864.
2019-03-20
TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility
PLoS ONE. 2019 Mar 20;14(3):Article number e0213463.
2019-03
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
Scientific Reports. 2019 Mar;9:Article number 3931.
2019-02
The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients
Cancer Epidemiology, Biomarkers and Prevention. 2019 Feb;28(2):248-257.
2019-01-15
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase
European Journal of Medicinal Chemistry. 2019 Jan 15;162:612-630.
2018-12
Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells
Biochemical Pharmacology. 2018 Dec;158:327-338.
Showing items 1-25 of 254. (11 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback